News24 reports that the people buying the unapproved weight loss drug include ordinary suburban parents with steady jobs.
Recap by typeshit. Full story at News24.
NewsNation reports doctors' guidance on pausing GLP-1 medications ahead of pregnancy. The full story has their reasoning.
The piece examines claims that taking smaller GLP-1 doses brings weight loss with fewer side effects, and asks how well that holds up.
10 News reports Australians are ending up in hospital after using unregulated peptides, prompting warnings from two state health departments.
A former peptide chemist covered the AAPM conference as the FDA weighs letting pharmacies compound BPC-157 and others, and found sizable gaps in the evidence advocates cite.
EMY says a newer group of obesity drugs is beating Ozempic, though the drugs and data behind the claim aren't named here.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Loading…